Tifacogin

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameTifacogin
Drug Alias NameTifacogina替法可近TifacogineTifacoginum
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionCoagulation factor VII inhibitorsCoagulation factor X inhibitors
TargetsCoagulation factor VIICoagulation factor X
Therapy Area/IndicationsPneumonia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[18] 
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Pharma Ag
Active IndicationsN/A
Inactive IndicationsPneumonia

Other Information

ATC CodeN/A
Related LinksN/A